Image Recognition
By MICHELLE CHAPMAN (AP Business Writer)WeightWatchers’ stock soared Tuesday after the company said it is getting into the prescription drug weight loss business with the acquisition of Sequence. Ozempic is approved only to treat diabetes, although it has been increasingly prescribed for off-label use. In a clinical trial, adults who used Wegovy lost about 15% of their initial body weight, while teens lost slightly more. Trulicity is a different drug, dulaglutide, used to treat diabetes in adults and children ages 10 and older. “This deal brings access to prescription drug solutions for weight loss to WW’s historical focus on behavior modification model,” wrote UBS analyst Michael Lasser.